Impairment of calcium ATPases by high glucose and potential pharmacological protection

References

• Squier TC. Oxidative stress and protein aggregation during biological aging. Exp Gerontol 2001;36:1539–1550.
   PubMed Web of Science ®Google Scholar
• Squier TC, Bigelow DJ. Protein oxidation and age-dependent alterations in calcium homeostasis. Front Biosci 2000;5: 504–526.
   PubMed Web of Science ®Google Scholar
• Levine RL, Mosoni L, Berlett BS, Stadtman ER. Methionine residues as endogenous antioxidants in proteins. Proc Natl Acad Sci U S A 1996;93:15036–15040.
   PubMed Web of Science ®Google Scholar
• Moreau R, Heath SHD, Doneanu CE, Lindsay JG, Hagen TM. Age-related increase in 4-hydroxynonenal adduction to rat heart alpha-ketoglutarate dehydrogenase does not cause loss of its catalytic activity. Antioxid Redox Sign 2003;5:517–527.
   PubMed Web of Science ®Google Scholar
• Gao J, Yin DH, Yao Y, Sun H, Qin Z, Schöneich C, et al. Loss of conformational stability in calmodulin upon methionine oxidation. Biophys J 1998;74:1115–1134.
   PubMed Web of Science ®Google Scholar
• Viner RI, Ferrington DA, Williams TD, Bigelow DJ, Schoneich C. Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem J 1999;340:657–669.
   PubMed Web of Science ®Google Scholar
• Chen B, Jones TE, Bigelow DJ. The nucleotide-binding site of the sarcoplasmic reticulum Ca-ATPase is conformationally altered in aged skeletal muscle. Biochemistry 1999; 38:14887–14896.
   PubMed Web of Science ®Google Scholar
• Bers DM. Calcium fluxes involved in control of cardiac myocyte contraction. Circ Res 2000;87:275–281.
   PubMed Web of Science ®Google Scholar
• Adachi T. Modulation of vascular sarco/endoplasmic reticulum calcium ATPase in cardiovascular pathophysiology. Adv Pharmacol 2010;59:165–195.
   PubMedGoogle Scholar
• Brini M, Carafoli E. Calcium pumps in health and disease. Physiol Rev 2009;89:1341–1378.
   PubMed Web of Science ®Google Scholar
• MacLennan DH, Rice WJ, Green NM. The mechanism of Ca2+ transport by sarco(endo)plasmic reticulum Ca2+-ATPases. J Biol Chem 1997;272:28815–28818.
   PubMed Web of Science ®Google Scholar
• Magnier-Gaubil C, Herbert JM, Quarck R, Papp B, Corvazier E, Wuytack F, et al. Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sarco-endoplasmic reticulum Ca2+ATPase regulation. J Biol Chem 1996;271:27788–27794.
   PubMed Web of Science ®Google Scholar
• Magnier C, Papp B, Corvazier E, Bredoux R, Wuytack F, Eggermont J, et al. Regulation of sarco-endoplasmic reticulum Ca(2+)-ATPases during platelet-derived growth factor-induced smooth muscle cell proliferation. J Biol Chem 1992;267:15808–15815.
   PubMed Web of Science ®Google Scholar
• Dode L, Vilsen B, Van Baelen K, Wuytack F, Clausen JD, Andersen JP. Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 3 isoforms by steady-state and transient kinetic analyses. J Biol Chem 2002;277:45579–45591.
   PubMed Web of Science ®Google Scholar
• Hovnanian A. SERCA pumps and human diseases. Subcell Biochem 2007;45:337–363.
   PubMedGoogle Scholar
• Tang WH, Cheng WT, Kravtsov GM, Tong XY, Hou XY, Chung SK, Chung SS. Cardiac contractile dysfunction during acute hyperglycemia due to impairment of SERCA by polyol pathway-mediated oxidative stress. Am J Physiol Cell Physiol 2010;299:643–653.
   PubMed Web of Science ®Google Scholar
• Inesi G, Hua S, Xu C, Ma H, Seth M, Prasad AM, Sumbilla C. Studies of Ca2+ ATPase (SERCA) inhibition. J Bioenerg Biomembr 2005;37:365–368.
   PubMed Web of Science ®Google Scholar
• Díaz ME, Graham HK, O’Neill SC, Trafford AW, Eisner DA. The control of sarcoplasmic reticulum Ca content in cardiac muscle. Cell Calcium 2005;38:391–396.
   PubMed Web of Science ®Google Scholar
• Belke DD, Dillmann WH. Altered cardiac calcium handling in diabetes. Curr Hypertens Rep 2004;6:424–429.
   PubMed Web of Science ®Google Scholar
• Adachi T, Weisbrod RM, Pimentel DR, Ying J, Sharov VS, Schöneich C, Cohen RA. S-Glutathiolation by peroxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat Med 2004;10:1200–1207.
   PubMed Web of Science ®Google Scholar
• Lipskaia L, del Monte F, Capiod T, Yacoubi S, Hadri L, Hours M, et al. Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat. Circ Res 2005;97: 488–495.
   PubMed Web of Science ®Google Scholar
• Sharov VS, Dremina ES, Galeva NA, Williams TD, Schoneich C. Quantitative mapping of oxidation-sensitive cysteine residues in SERCA in vivo and in vitro by HPLC-electrospray-tandem MS: selective protein oxidation during biological aging. Biochem J 2006;394:605–615.
   PubMed Web of Science ®Google Scholar
• Ying J, Sharov V, Xu S, Jiang B, Gerrity R, Schoneich C, Cohen RA. Cysteine-674 oxidation and degradation of sarcoplasmic reticulum Ca(2+) ATPase in diabetic pig aorta. Free Radic Biol Med 2008;45:756–762.
   PubMed Web of Science ®Google Scholar
• Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000;18: 655–673.
   PubMed Web of Science ®Google Scholar
• Knyushko TV, Sharov VS, Williams TD, Schoneich C, Bigelow DJ. 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry 2005;44:13071–13081.
   PubMed Web of Science ®Google Scholar
• Adachi T, Matsui R, Xu S, Kirber M, Lazar HL, Sharov VS, et al. Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res 2002;90:1114–1121.
   PubMed Web of Science ®Google Scholar
• Xu S, Ying J, Jiang B, Guo W, Adachi T, Sharov V, et al. Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol 2006;290: H2220–2227.
   PubMed Web of Science ®Google Scholar
• Schoneich C, Sharov VS. Mass spectrometry of protein modifications by reactive oxygen and nitrogen species. Free Radic Biol Med 2006;41:1507–1520.
   PubMed Web of Science ®Google Scholar
• Lounsbury KM, Hu Q, Ziegelstein RC. Calcium signaling and oxidant stress in the vasculature. Free Radic Biol Med 2000;28:1362–1369.
   PubMed Web of Science ®Google Scholar
• Chung SSM, Chung SK. Aldose reductase in diabetic microvascular complications. Curr Drug Targets 2005;6: 475–486.
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Ramana KV, Bhatnagar A. Role of aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 2005;26:380–392.
   PubMed Web of Science ®Google Scholar
• Chung SSM, Chung SK. Genetic analysis of aldose reductase in diabetic complications. Curr Med Chem 2003;10: 1375–1387.
   PubMed Web of Science ®Google Scholar
• Lee AY, Chung SS. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J 1999;13: 23–30.
   PubMed Web of Science ®Google Scholar
• Bassenge E, Sommer O, Schwemmer M, Bünger R. Antioxidant pyruvate inhibits cardiac formation of reactive oxygen species through changes in redox state. Am J Physiol Heart Circ Physiol 2000;279:2431–2438.
   PubMed Web of Science ®Google Scholar
• Mohazzab-H KM, Kaminski PM, Wolin MS. Lactate and PO2 modulate superoxide anion production in bovine cardiac myocytes: potential role of NADH oxidase. Circulation 1997;96:614–620.
   PubMed Web of Science ®Google Scholar
• Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca(2+)-ATPase function by direct attack on the ATP binding site. Circ Res 1997;80:76–81.
   PubMed Web of Science ®Google Scholar
• Ramasamy R, Oates PJ, Schaefer S. Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 1997;46:292–300.
   PubMed Web of Science ®Google Scholar
• Oswald GA, Smith CC, Betteridge DJ, Yudkin JS. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 1986;293:917–922.
   PubMed Web of Science ®Google Scholar
• Tang WH, Wu S, Wong TM, Chung SK, Chung SSM. Polyol pathway mediates iron-induced oxidative injury in ischemic-reperfused rat heart. Free Radic Biol Med 2008; 45:602–610.
   PubMed Web of Science ®Google Scholar
• Tang WH, Kravtsov GM, Sauert M, Tong XY, Hou XY, Wong TM, et al. Polyol pathway impairs the function of SERCA and RyR in ischemic-reperfused rat hearts by increasing oxidative modifications of these proteins. J Mol Cell Cardiol 2010;49:58–69.
   PubMed Web of Science ®Google Scholar
• Ceriello A, Quagliaro L, D’Amico M, Di Filippo C, Marfella R, Nappo F, et al. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002;51:1076–1082.
   PubMed Web of Science ®Google Scholar
• Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006;295: 1681–1687.
   PubMed Web of Science ®Google Scholar
• Ying J, Tong X, Pimentel DR, Weisbrod RM, Trucillo MP, Adachi T, Cohen RA. Cysteine-674 of the sarco/endoplasmic reticulum calcium ATPase is required for the inhibition of cell migration by nitric oxide. Arterioscler Thromb Vasc Biol 2007;27:783–790.
   PubMed Web of Science ®Google Scholar
• Tong X, Evangelista A, Cohen RA. Targeting the redox regulation of SERCA in vascular physiology and disease. Curr Opin Pharmacol 2010;10:133–138.
   PubMed Web of Science ®Google Scholar
• Tong X, Ying J, Pimentel DR, Trucillo M, Adachi T, Cohen RA. High glucose oxidizes SERCA cysteine-674 and prevents inhibition by nitric oxide of smooth muscle cell migration. J Mol Cell Cardiol 2008;44:361–369.
   PubMed Web of Science ®Google Scholar
• Tong X, Hou X, Jourd'heuil D, Weisbrod RM, Cohen RA. Upregulation of Nox4 by TGF{beta}1 oxidizes SERCA and inhibits NO in arterial smooth muscle of the prediabetic Zucker rat. Circ Res 2010;107:975–983.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Taguchi K, Takenouchi Y, Matsumoto T, Kamata K. Insulin-induced impairment via peroxynitrite production of endothelium-dependent relaxation and sarco/endoplasmic reticulum Ca(2+)-ATPase function in aortas from diabetic rats. Free Radic Biol Med 2007;43: 431–443.
   PubMed Web of Science ®Google Scholar
• Pandolfi A, Iacoviello L, Capani F, Vitacolonna E, Donati MB, Consoli A. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture. Diabetologia 1996;39:1425–1431.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Oishi K, Hayashi Y, Matsumoto T, Kamata K. Changes in aortic endothelial gene expressions and relaxation responses following chronic short-term insulin treatment in diabetic rats. Atherosclerosis 2006;185: 47–57.
   PubMed Web of Science ®Google Scholar
• Randriamboavonjy V, Pistrosch F, Bolck B, Schwinger RHG, Dixit M, Badenhoop K, et al. Platelet sarcoplasmic endoplasmic reticulum Ca2+-ATPase and mu-calpain activity are altered in type 2 diabetes mellitus and restored by rosiglitazone. Circulation 2008;117:52–60.
   PubMed Web of Science ®Google Scholar
• Schaefer W, Beeker J, Gries FA. Influence of hyperglycemia on Ca2+-Mg2+ -ATPase of red blood cells from diabetic patients. Klin Wochenschr 1988;66:443–446.
   PubMedGoogle Scholar
• Schaefer W, Priessen J, Mannhold R, Gries AF. Ca2+-Mg2+-ATPase activity of human red blood cells in healthy and diabetic volunteers. Klin Wochenschr 1987;65:17–21.
   PubMedGoogle Scholar
• González Flecha FL, Bermúdez MC, Cédola N V, Gagliardino JJ, Rossi JP. Decreased Ca2(+)-ATPase activity after glycosylation of erythrocyte membranes in vivo and in vitro. Diabetes 1990;39:707–711.
   PubMed Web of Science ®Google Scholar
• Gonzalez Flecha FL, Castello PR, Caride AJ, Gagliardino JJ, Rossi JP. The erythrocyte calcium pump is inhibited by non-enzymic glycation: studies in situ and with the purified enzyme. Biochem J 1993;293:369–375.
   PubMed Web of Science ®Google Scholar
• González Flecha FL, Castello PR, Gagliardino JJ, Rossi JP. Molecular characterization of the glycated plasma membrane calcium pump. J Membr Biol 1999;171:25–34.
   PubMed Web of Science ®Google Scholar
• Bidasee KR, Zhang Y, Shao CH, Wang M, Patel KP, Dincer UD, Besch HR Jr. Diabetes increases formation of advanced glycation end products on Sarco(endo)plasmic reticulum Ca2+-ATPase. Diabetes 2004;53:463–473.
   PubMed Web of Science ®Google Scholar
• Raftos JE, Edgley A, Bookchin RM, Etzion Z, Lew VL, Tiffert T. Normal Ca2+ extrusion by the Ca2+ pump of intact red blood cells exposed to high glucose concentrations. Am J Physiol Cell Physiol 2001;280:1449–1454.
   Web of Science ®Google Scholar
• Bookchin RM, Etzion Z, Lew VL, Tiffert T. Preserved function of the plasma membrane calcium pump of red blood cells from diabetic subjects with high levels of glycated haemoglobin. Cell Calcium 2009;45:260–263.
   PubMed Web of Science ®Google Scholar
• Rossi JPFC, Villamil AM, Echarte MM, Alzugaray ME, Borelli MI, García ME, et al. Plasma membrane calcium pump activity in rat pancreatic islets: an accurate method to measure its calcium-dependent modulation. Cell Biochem Biophys 2006;46:193–200.
   PubMedGoogle Scholar
• Herchuelz A, Kamagate A, Ximenes H, Van Eylen F. Role of Na/Ca exchange and the plasma membrane Ca2+-ATPase in beta cell function and death. Ann N Y Acad Sci 2007; 1099:456–467.
   PubMed Web of Science ®Google Scholar
• Levi V, Villamil Giraldo AM, Castello PR, Rossi JPFC, González Flecha FL. Effects of phosphatidylethanolamine glycation on lipid-protein interactions and membrane protein thermal stability. Biochem J 2008;416:145–152.
   PubMed Web of Science ®Google Scholar
• Ulrich P, Cerami A. Protein glycation, diabetes, and aging. Recent Prog Horm Res 2001;56:1–21.
   PubMedGoogle Scholar
• Cho S-J, Roman G, Yeboah F, Konishi Y. The road to advanced glycation end products: a mechanistic perspective. Curr Med Chem 2007;14:1653–1671.
   PubMed Web of Science ®Google Scholar
• Oliver CM, Melton LD, Stanley RA. Creating proteins with novel functionality via the Maillard reaction: a review. Crit Rev Food Sci Nutr 2006;46:337–350.
   PubMed Web of Science ®Google Scholar
• Reddi AS, Dasmahapatra A, Jyothirmayi GN, Jayasundaramma B. Erythrocyte Ca, Na/K-ATPase in long-term streptozotocin diabetic rats. Effect of good glycemic control and a Ca antagonist. Am J Hypertens 1992;5:863–868.
   Google Scholar
• Norby FL, Wold LE, Duan J, Hintz KK, Ren J. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes. Am J Physiol Endocrinol Metab 2002;283:658–666.
   Web of Science ®Google Scholar
• Li Q, Wu S, Li S-Y, Lopez FL, Du M, Kajstura J, et al. Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage. Am J Physiol Heart Circ Physiol 2007;292:1398–1403.
   Web of Science ®Google Scholar
• Nandhini TA, Anuradha CV. Inhibition of lipid peroxidation, protein glycation and elevation of membrane ion pump activity by taurine in RBC exposed to high glucose. Clin Chim Acta 2003;336:129–135.
   PubMed Web of Science ®Google Scholar
• Wu QD, Wang JH, Fennessy F, Redmond HP, Bouchier-Hayes D. Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis. Am J Physiol 1999;277:1229–1238.
   PubMed Web of Science ®Google Scholar
• Ogasawara M, Nakamura T, Koyama I, Nemoto M, Yoshida T. Reactivity of taurine with aldehydes and its physiological role. Adv Exp Med Biol 1994;359:71–78.
   PubMedGoogle Scholar
• Franconi F, Bennardini F, Mattana A, Miceli M, Ciuti M, Mian M, et al. Plasma and platelet taurine are reduced in subjects with insulin-dependent diabetes mellitus: effects of taurine supplementation. Am J Clin Nutr 1995;61: 1115–1119.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lim DM, Park HS, Moon CI, Choi KJ, Lee SK, et al. Exendin-4 protects against sulfonylurea-induced β-cell apoptosis. J Pharmacol Sci 2012;118:65–74.
   Web of Science ®Google Scholar
• Kamboj SS, Chopra K, Sandhir R. Hyperglycemia-induced alterations in synaptosomal membrane fluidity and activity of membrane bound enzymes: beneficial effect of N-acetylcysteine supplementation. Neuroscience 2009;162: 349–358.
   PubMed Web of Science ®Google Scholar
• Kim HW, Ch YS, Lee HR, Park SY, Kim YH. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression. Life Sci 2001;70: 367–379.
   PubMed Web of Science ®Google Scholar
• Brittsan AG, Carr AN, Schmidt AG, Kranias EG. Maximal inhibition of SERCA2 Ca(2+) affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J Biol Chem 2000;275:12129–12135.
   PubMed Web of Science ®Google Scholar
• Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J Biol Chem 1995;270: 12953–12956.
   PubMed Web of Science ®Google Scholar
• Kono T, Ahn G, Moss DR, Gann L, Zarain-Herzberg A, Nishiki Y, et al. PPAR-γ activation restores pancreatic islet SERCA2 levels and prevents β-cell dysfunction under conditions of hyperglycemic and cytokine stress. Mol Endocrinol 2012;26:257–271.
   PubMedGoogle Scholar
• Shah RD, Gonzales F, Golez E, Augustin D, Caudillo S, Abbott A, et al. The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alpha-induced IL-6 secretion in ventricular myocytes. Cell Physiol Biochem 2005;15:41–50.
   PubMedGoogle Scholar
• Jardin I, Redondo PC, Salido GM, Pariente JA, Rosado JA. Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non- insulin-dependent diabetes mellitus. Platelets 2006;17: 283–288.
   PubMed Web of Science ®Google Scholar
• Ren J, Li Q, Wu S, Li SY, Babcock SA. Cardiac overexpression of antioxidant catalase attenuates aging-induced cardiomyocyte relaxation dysfunction. Mech Ageing Dev 2007;128:276–285.
   PubMed Web of Science ®Google Scholar
• Babu PVA, Sabitha KE, Shyamaladevi CS. Therapeutic effect of green tea extract on oxidative stress in aorta and heart of streptozotocin diabetic rats. Chem Biol Interact 2006;162:114–120.
   PubMed Web of Science ®Google Scholar
• Arnér ES, Nordberg J, Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 1996;225:268–274.
   PubMed Web of Science ®Google Scholar
• Constantinescu A, Pick U, Handelman GJ, Haramaki N, Han D, Podda M, et al. Reduction and transport of lipoic acid by human erythrocytes. Biochem Pharmacol 1995;50: 253–261.
   PubMed Web of Science ®Google Scholar
• Jain SK, Lim G. Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))- and Ca(++)-ATPase activities in high glucose-treated human erythrocytes. Free Radic Biol Med 2000;29:1122–1128.
   PubMed Web of Science ®Google Scholar
• Vasanji Z, Cantor EJF, Juric D, Moyen M, Netticadan T. Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance. Am J Physiol Cell Physiol 2006;291: 772–780.
   Web of Science ®Google Scholar
• Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 2004;53:3201–3208.
   PubMed Web of Science ®Google Scholar
• Wang M, Zhang WB, Zhu JH, Fu GS, Zhou BQ. Breviscapine ameliorates cardiac dysfunction and regulates the myocardial Ca(2+)-cycling proteins in streptozotocin- induced diabetic rats. Acta diabetol 2010;47:209–218.
   PubMed Web of Science ®Google Scholar
• Pekiner B, Ulusu NN, Das-Evcimen N, Sahilli M, Aktan F, Stefek M, et al. In vivo treatment with stobadine prevents lipid peroxidation, protein glycation and calcium overload but does not ameliorate Ca2+ -ATPase activity in heart and liver of streptozotocin-diabetic rats: comparison with vitamin E. Biochim Biophys Acta 2002;1588:71–78.
   PubMed Web of Science ®Google Scholar
• Das Evcimen N, Ulusu NN, Karasu C, Doğru B. Adenosine triphosphatase activity of streptozotocin-induced diabetic rat brain microsomes. Effect of vitamin E. Gen Physiol Biophys 2004;23:347–355.
   PubMed Web of Science ®Google Scholar
• Kowluru RA, Kern TS, Engerman RL, Armstrong D. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. III. Effects of antioxidants. Diabetes 1996;45:1233–1237.
   PubMed Web of Science ®Google Scholar
• Pieper GM, Dembny K, Siebeneich W. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction. Diabetologia 1998;41:1220–1226.
   PubMed Web of Science ®Google Scholar
• Taguchi K, Kobayashi T, Hayashi Y, Matsumoto T, Kamata K. Enalapril improves impairment of SERCA- derived relaxation and enhancement of tyrosine nitration in diabetic rat aorta. Eur J Pharmacol 2007;556:121–128.
   PubMed Web of Science ®Google Scholar
• Park SW, Zhou Y, Lee J, Lee J, Ozcan U. Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity. Proc Natl Acad Sci U S A 2010;107:19320–19325.
   PubMed Web of Science ®Google Scholar
• Sakata S, Lebeche D, Sakata Y, Sakata N, Chemaly ER, Liang L, et al. Transcoronary gene transfer of SERCA2a increases coronary blood flow and decreases cardiomyocyte size in a type 2 diabetic rat model. Am J Physiol Heart Circ Physiol 2007;292:1204–1207.
   PubMed Web of Science ®Google Scholar
• Levitsky DO, Clergue M, Lambert F, Souponitskaya MV, Le Jemtel TH, Lecarpentier Y, et al. Sarcoplasmic reticulum calcium transport and Ca(2+)-ATPase gene expression in thoracic and abdominal aortas of normotensive and spontaneously hypertensive rats. J Biol Chem 1993;268: 8325–8331.
   PubMed Web of Science ®Google Scholar
• Jaski BE, Jessup ML, Mancini DM, Cappola TP, Pauly DF, Greenberg B, et al; Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) Trial Investigators. Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase clinical trial. J Card Fail 2009;15:171–181.
   PubMed Web of Science ®Google Scholar
• Nolly HL, Saed G, Scicli G, Carretero OA, Scicli AG. The kallikrein-kinin system in cardiac tissue. Agents Actions Suppl 1992;38:62–72.
   PubMedGoogle Scholar
• Tschope C, Walther T, Yu M, Reinecke A, Koch M, Seligmann C, et al. Myocardial expression of rat bradykinin receptors and two tissue kallikrein genes in experimental diabetes. Immunopharmacology 1999;44:35–42.
   PubMedGoogle Scholar
• Sharma JN, Uma K, Yusof AP. Left ventricular hypertrophy and its relation to the cardiac kinin-forming system in hypertensive and diabetic rats. Int J Cardiol 1998;63:229–235.
   PubMed Web of Science ®Google Scholar
• Levin SR, Kasson BG, Driessen JF. Adenosine triphosphatases of rat pancreatic islets: comparison with those of rat kidney. J Clin Invest 1978;62:692–701.
   PubMed Web of Science ®Google Scholar
• Kulkarni RN, Roper MG, Dahlgren G, Shih DQ, Kauri LM, Peters JL, et al. Islet secretory defect in insulin receptor substrate 1 null mice is linked with reduced calcium signaling and expression of sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA)-2b and -3. Diabetes 2004;53:1517–1525.
   PubMed Web of Science ®Google Scholar
• Borge PD, Wolf BA. Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting beta-cells. J Biol Chem 2003;278:11359–11368.
   PubMed Web of Science ®Google Scholar
• Xu GG, Gao ZY, Borge PD, Jegier PA, Young RA, Wolf BA. Insulin regulation of beta-cell function involves a feedback loop on SERCA gene expression, Ca(2+) homeostasis, and insulin expression and secretion. Biochemistry 2000;39: 14912–14919.
   PubMed Web of Science ®Google Scholar
• Depre C, Young ME, Ying J, Ahuja HS, Han Q, Garza N, et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol 2000;32:985–996.
   PubMed Web of Science ®Google Scholar
• Chen X, Yang L, Zhai S. Risk of cardiovascular disease and all-cause mortality among diabetic patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies. Chin Med J 2012;125:4301–4306.
   PubMed Web of Science ®Google Scholar
• Wu W, Li Q, Xia J, Wang M, Sun Z, Miao J, Zheng Z. Effects of the glucose-lowering rate on cTnI and hs-CRP serum levels in type 2 diabetics. Hum Immunol 2013;74: 379–382.
   PubMed Web of Science ®Google Scholar
• Zhou H, Liu D, Liang C. Challenges and strategies: the immune responses in gene therapy. Med Res Rev 2004;24:748–761.
   PubMed Web of Science ®Google Scholar
• Dode L, Andersen JP, Leslie N, Dhitavat J, Vilsen B, Hovnanian A. Dissection of the functional differences between sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses. J Biol Chem 2003;278:47877–47889.
   Google Scholar